Mukaltin tablets 50mg, No. 20
Expiration Date: 05/2027
Russian Pharmacy name:
Мукалтин таблетки 50мг, №20
Adults and children from 12 years old inside 1-2 tablets 2-3 times a day before meals. The course of treatment is on average 7-14 days. Children can dissolve the tablet in 1/3 cup of warm water.
Active ingredient:
marshmallow herb extract (mucaltin) - 50.0 mg;
excipients: tartaric acid - 43.25 mg, calcium phosphate 2-substituted anhydrous (calcium hydrogen phosphate anhydrous) - 179.75 mg, crospovidone (crospovidone CL-M) - 21.0 mg, povidone (low molecular weight medical polyvinylpyrrolidone, povidone K 17 ) - 3.0 mg, calcium stearate - 3.0 mg.
Hypersensitivity to the components of the drug,
peptic ulcer of the stomach and duodenum,
children under 12 years of age.
Pharmacological properties
Mukaltin is a mixture of polysaccharides from the herb marshmallow with expectorant properties. Thanks to reflex stimulation, it enhances the activity of the ciliated epithelium and the peristalsis of the respiratory bronchioles in combination with an increase in the secretion of the bronchial glands.
Application during pregnancy and during breastfeeding
The use of the drug during pregnancy and during breastfeeding is possible on the recommendation of a doctor.
Side effect
Allergic reactions, rarely - dyspeptic symptoms.
Overdose
To date, no cases of overdose have been reported.
Interaction with other medicinal products
Mukaltin can be administered concurrently with other drugs used in the treatment of bronchopulmonary diseases.
Mukaltin should not be used concurrently with drugs containing codeine and other antitussive drugs, as this makes it difficult to cough up liquefied sputum.
Influence on the ability to drive vehicles and mechanisms
The drug does not affect the ability to perform potentially hazardous activities that require increased concentration of attention and speed of psychomotor reactions (including driving, working with moving mechanisms).